Preclinical data on UCART20x22, Cellectis’ first allogeneic dual CAR T-cell product candidate to treat B-NHL,…
BOSTON, June 05, 2023 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage…
BOSTON, June 05, 2023 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage…
SAN FRANCISCO, June 05, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
SAN FRANCISCO, June 05, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), Humacyte, Inc. (Nasdaq:…
DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), Humacyte, Inc. (Nasdaq:…
PETACH TIKVA, Israel, June 05, 2023 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”),…
PETACH TIKVA, Israel, June 05, 2023 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”),…
All 7 out of 7 eligible patients with relapsed/refractory chronic lymphocytic leukemia (rrCLL), with or…
All 7 out of 7 eligible patients with relapsed/refractory chronic lymphocytic leukemia (rrCLL), with or…
ERAS-007 100 mg BID-QW + encorafenib + cetuximab (EC) in EC-naïve patients with BRAFm CRC…
ERAS-007 100 mg BID-QW + encorafenib + cetuximab (EC) in EC-naïve patients with BRAFm CRC…
BEDFORD, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company…
BEDFORD, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company…
CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage…
CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage…
Aggregate Gross Proceeds of $143.7 Million from Public Offering and Private Placement THE WOODLANDS, Texas,…
Experienced Nuclear Leader Jon Ball Named to Lead Next Phase of Global Deployment CRANBERRY TOWNSHIP,…
Vancouver, British Columbia–(Newsfile Corp. – June 5, 2023) – Hillcrest Energy Technologies (CSE: HEAT) (OTCQB:…